AzTrials
AzTrials

Urethral StrictureNCT05519566

The Accuracy of Pulsed Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram In Diagnosing Urethral Stricture

A study testing Retrograde Urethrogram in people with Urethral Stricture, run by Northern Ontario School of Medicine at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is designed as a prospective comparative randomized clinical study to determine the diagnostic accuracy (sensitivity, specificity, positive predictive value, and negative predictive value) of pulsed fluoroscopy retrograde urethrogram for urethral stricture disease. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Urethral Stricture
What is being tested?
Retrograde Urethrogram
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteCanada
Study dates
1 Sep 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Males over 18 years of age at the time of enrollment
  • Referred to urology for a suspected diagnosis of stricture urethra.
  • Ability to get written informed consent to participate
  • Ability to comply with study procedures

Who cannot join

  • Co-existing urethral fistula, or requiring fluoroscopic guided manipulation
  • Active urinary tract infection not yet appropriately treated
  • Pre-existing conditions, which, in the opinion of the investigator, interfere with the conduct of the study
  • Lack of capacity to provide free and informed written consent

Trial locations and contacts

1 site in 1 country.

Walid Shahrour, MD contact

(807) 285-9292

Walid.Shahrour@tbh.net

Vahid Mehrnoush, MD contact

(807) 285-9292

vahidmehrnoush7@gmail.com

Canada1 site, 1 recruiting
  • Thunder Bay Regional Health Science Centre

    Thunder Bay, Ontario, P7B 6V4

    Walid Shahrour, MD, (807) 285-9292, Walid.Shahrour@tbh.net

    Walid.Shahrour@tbh.net

    Recruiting

Other trials in Canada

About this study

Official title: The Diagnostic Accuracy of Pulsed Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram In Diagnosing Urethral Stricture: A Randomized Prospective Comparative Study

This study is designed as a prospective comparative randomized clinical study to determine the diagnostic accuracy (sensitivity, specificity, positive predictive value, and negative predictive value) of pulsed fluoroscopy retrograde urethrogram for urethral stricture disease. The target population includes patients scheduled for retrograde urethrogram either new referral or follow up at Thunder Bay Regional Health Sciences Centre (TBRHSC) for treatment of urethral stricture who meet the specific eligibility criteria. The overall number of participants targeted will be 46. Upon presentation to the urology clinic or ambulatory care unit, the treating urologist/investigator will notify the patient of an opportunity to participate in the study. If the patient is interested, a research team member who is not directly involved in the patient care will be invited to discuss the study to the potential participant.

The study team member will obtain a full-informed consent form the potential participant.

Read more

Following informed consent, participants will be screened to ensure they meet the specific eligibility requirements of this study, through consultation with their medical records and the treating urologist. Randomization will be conducted in a 1:1 allocation ratio to either treatment arm: (1) the Pulsed fluoroscopy retrograde urethrogram, or (2) the Traditional retrograde urethrogram.

Using an Excel sheet, the RAND function will give a random code. The random code is a figure ranging from 0.00000000 to 0.9999999999. A 0.5 cut-off code will be used, below which we will use the small blocks of 4 cells (4 rows of excel) and above which we will use the large blocks of 8 cells (8 rows of excel). Participants will undergo procedures according to the order of randomization Participants will undergo either Pulsed fluoroscopy retrograde urethrogram or Traditional retrograde urethrogram, depending on the treatment arm they are randomized to. Clinical data such as stricture location, stricture length and possible adverse effects will be recorded. According to the urologist decision based on data obtained during RUG, participant will be scheduled for urethroplasty or cystoscopy. All participants will undergo these procedures according to standard care procedures at TBRHSC.

Data collection at baseline will include demographics, and relevant medical history. All retrograde urethrogram data including the type of urethrogram, the urethrogram date, fluoroscopy time, cumulative radiation dose, stricture location, stricture length and intraprocedural complications.

Furthermore, we will record intraoperative data such as operative date, stricture location and stricture length. De-identified research files will be maintained in a secure office of a research team member during the conduct of the study. De-identified research data will be input into an electronic database that is password protected and maintained on research team member's computers or encrypted USB devices. An enrolment log, linking Participant ID to identifiable information will be maintained in hard copy in a locked office, or electronically as a password-protected document on the TBRHSC network.

Only delegated research team members and the Principal Investigator will have access to research and patient data.

Upon study closure, research records will be kept in secure storage in a research team member's office for a period of 5 years. Following this, the files will be securely shredded, and any electronic documents permanently deleted.

Data will be analyzed using the commercially available SPSS software version 26 (SPSS Inc., Chicago, IL, USA). For both techniques, data obtained during baseline and postoperative urethrograms will be compared in terms of stricture location, stricture length, fluoroscopy time, cumulative radiation dose and the occurrence of intraprocedural complications. Categorical data will be compared using Chi-squared or Fisher test. Continuous data will be analyzed using the T test or Mann-Whitney U test

Data obtained during urethroplasty will set as a standard of comparison to determine sensitivity, specificity, positive predictive value and negative predictive value of pulsed fluoroscopy and traditional urethrograms. For each comparison, 2 × 2 contingency tables were used to present the results and calculate the diagnostic accuracy estimates with 95% confidence intervals Data analysis will be done blindly regarding the type of performed procedure. One procedure will be coded as "1" and the other will "2". Categorical variables will be presented using number and percentage, and continuous variables will be presented using median and ranges. Two-tailed p-values of less than 0.05 will be set for statistical significance.

Being tested
Retrograde Urethrogram
Keywords
Diagnosing Urethral Stricture, Pulsed Fluoroscopy Retrograde Urethrogram, Traditional Retrograde Urethrogram
Medical subject headings
Urethral Stricture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrograde UrethrogramDiagnostic test

    Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram

Study groups in NCT05519566
Study groupRoleWhat they receive
Pulsed Fluoroscopy Retrograde UrethrogramExperimentalNot described
Receives: Diagnostic Test: Retrograde Urethrogram
Traditional Retrograde UrethrogramActive comparatorNot described
Receives: Diagnostic Test: Retrograde Urethrogram

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. diagnostic accuracy of pulsed fluoroscopy retrograde urethrogram

    Sensitivity, specificity, positive predictive value, and negative predictive value of pulsed fluoroscopy retrograde urethrogram

    Measured: Intra-procedure (during the urethroplasty)

  2. diagnostic accuracy of pulsed traditional retrograde urethrogram

    Sensitivity, specificity, positive predictive value, and negative predictive value of pulsed traditional retrograde urethrogram

    Measured: Intra-procedure (during the urethroplasty)

Secondary outcomes (1)
  1. Intraprocedural adverse events

    Any adverse events (e.g., extravasation of contrast)

    Measured: Intra-procedure (during the urethroplasty)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2022
  2. Study start1 Sep 2022
  3. Primary completion31 Oct 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05519566
Sponsor's protocol ID
2021515
Status last verified
May 2023
First submitted
25 Aug 2022
Last updated
15 May 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Retrograde Urethrogram in people with Urethral Stricture, run by Northern Ontario School of Medicine at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Walid Shahrour, MD ((807) 285-9292, Walid.Shahrour@tbh.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

diagnostic accuracy of pulsed fluoroscopy retrograde urethrogram (time frame: Intra-procedure (during the urethroplasty)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in